Drugs for Severe Malaria

The Severe Malaria Observatory aims to increase the transparency and availability of information regarding severe malaria medicines and their market trends.

If you have additional information to share concerning severe malaria commodities or their market dynamics, please submit it here. We are specifically interested in receiving:

Manufacturer information and reports
Country drug registration updates
Procurement volumes
Drug pricing data

Severe malaria treatments

Drug Procurement Trends Africa

Severe malaria market situation

Injectable Artesunate

Rectal Artesunate Suppository

Artemether Injection

Injectable Quinine Treatment

MMV is not the marketing authorization holder for any of the products to which this document refers. Please refer to the full prescribing information and/or patient information supplied by the relevant marketing authorization holder for your country. Furthermore, policies and treatment guidelines may vary from country to country. Therefore, please consult local policies and treatment guidelines.

MMV accepts no liability for the information presented here, nor for the consequences of any actions taken on the basis of this information.

Severe Malaria Observatory

Knowledge sharing for severe malaria

Search